Provention Bio Inc (NASDAQ:PRVB)

15.21
Delayed Data
As of Sep 18
 +0.39 / +2.63%
Today’s Change
4.72
Today|||52-Week Range
18.50
+2.08%
Year-to-Date
New Strong Sell Stocks for September 8th
Sep 08 / Zacks.com - Paid Partner Content
Provention Bio initiates Phase 2b PROACTIVE study of PRV-015
Aug 31 / Seeking Alpha - Paid Partner Content
Is the Options Market Predicting a Spike in Provention Bio (PRVB) Stock?
Sep 08 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close14.82
Today’s open15.00
Day’s range14.88 - 15.43
Volume23,783
Average volume (3 months)943,237
Market cap$855.5M
Data as of 3:59pm ET, 09/18/2020

Growth & Valuation

Earnings growth (last year)+10.90%
Earnings growth (this year)-50.00%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.82

Competitors

 Today’s
change
Today’s
% change
VCELVericel Corp+0.06+0.32%
PETQPetIQ Inc-0.37-1.18%
CLLSCellectis SA+0.46+2.26%
----
Data as of 3:59pm ET, 09/18/2020

Financials

Next reporting dateNovember 5, 2020
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$0.00
Annual profit (last year)-$43.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Lebanon, New Jersey

Forecasts